Roma Vinodbhai Shah

Roma Vinodbhai Shah is a declared insider of Remus Pharmaceuticals Limited, with filings sourced from SEBI (PIT + SAST). In total, 20 filings cover trades dated from 27 September 2023 to 22 September 2025.

Purchases make up the whole of the open-market record (20 purchases, €475k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2025: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €5,795. 17 out of 20 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 23 September 2025 with an open-market purchase (€23k) in Remus Pharmaceuticals Limited. Typically, a trade is published a median of 1 day after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.